M2RLAB

Our mission is to provide physicians and patients innovative therapeutic tools for the treatment of damaged tissue that are efficient and safe, using a best in class technology that is affordable. We are currently developing three candidate blood cell therapies targeting: Acute Kidney Failure, Muscular Injury and ARDS. M2R lab is an R&D biotech company dedicated to develop innovative therapies to recover tissue and organ function in patients suffering from uncontrolled inflammation, a complication that leads to tissue degeneration and organ malfunction. Inflammation leading to irreversible tissue injury is mediated by macrophages, lymphocytes and cytokine release. Leukocyte phenotype is a key factor that modulate the regenerative process in injured tissues. We specialize in developing therapies that promote the polarization of cells in order to change its behavior, promoting repair by integrating the latest advances in immunobiology with preclinical and clinical research. M2R® is a new regenerative therapy that accelerates the repair process, regenerates tissue and reduces scars to minimum. Joaquín Juan is a Spanish physiotherapist specialized in the treatment of high-performance athletes, as well as a successful entrepreneur recognized in sports medicine.